arrow
P

Paolo Magistri

university of modena and reggio-emilia
H指数:31
被引数:3,495

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multicentre parallel-group open-label non-inferiority randomized clinical trial of recooling versus no recooling after normothermic machine perfusion in liver transplantation: ARANMP-LT protocol

多中心平行组开放标签非劣效性随机对照临床试验:在肝脏移植中,常温机器灌注后复温与不复温的比较:ARANMP-LT方案

2026-10-120
OAAI
Anatomical versus Non-Anatomical Liver Resection for Hepatocellular carcinoma – An International Multicenter Propensity Score-Matched Analysis of Short- and Long-term outcomes in an International Multicenter Cohort

解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的比较——一项国际多中心倾向性评分匹配分析短期和长期结局的国际多中心队列研究

HPB
IF2.4
2026-05-260
OAAI
Global Survey of Technical Preferences for Robotic Versus Laparoscopic Segmentectomy of Liver Segments 7 and 8: A 2024 PAM-HBP Surgery Project

全球范围内对于肝段7和8机器人与腹腔镜段切除术的技术偏好调查:一项2024年PAM-HBP手术项目

2026-05-200
PRE
Challenging anatomy, comparable outcomes: a multicenter propensity score-matched analysis of robotic hepatectomy in posterosuperior versus anterolateral segments

挑战性解剖,可比性结局:机器人肝切除术在背侧与腹侧肝段的多中心倾向性评分匹配分析

HPB
IF2.4
2026-02-130
OAAI
Life Expectancy of Transplanted Livers: HOPE Against Aging?

移植肝脏的预期寿命:HOPE对抗衰老?

2025-08-070
PREAI
Is robotic liver resection feasible in patients with lesions in close proximity to major vessels? A propensity score matching analysis

机器人肝脏切除术在病变邻近主要血管的患者中是否可行?一项倾向性评分匹配分析

HPB
IF2.4
2025-01-013
OAAI
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma
2024-08-010
OAAI
Vena cava replacement and major hepatectomy for liver tumors: international multicenter retrospective cohort study
2024-07-011
OAAI
Robotic Versus Laparoscopic Liver Resection in Various Settings An International Multicenter Propensity Score Matched Study of 10.075 Patients
2024-03-1420
OAAI
Portal vein thrombosis and liver transplantation: management, matching, and outcomes. A retrospective multicenter cohort study
2024-03-042
OAAI